ACOG: Protecting against HPV should begin early

Article

Vaccination against human papillomavirus should begin at age 11 and 12 years, according to ACOG committee opinion.

Vaccination against human papillomavirus (HPV) should begin at age 11 and 12 years, according to an American College of Obstetricians and Gynecologists committee opinion published in the September issue of Obstetrics and Gynecology. This opinion supports these same recommendations made by the federal Advisory Committee on Immunization Practices.

Girls as young as 9 years old can receive the vaccine, and those aged 13 through 26 years who have not received the vaccine should receive catch-up doses and complete the series of 3 vaccinations.

The vaccine is available in both bivalent and quadrivalent varieties. Both offer nearly 100% protection against precancerous changes in the cervix. The quadrivalent version also prevents lower genital tract condyloma. Patients should receive the vaccine before they become sexually active to gain maximum benefit; however, the vaccine can be given after a patient is sexually active.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Lori Handy, MD on importance of vaccine catch-up before the school year | Image credit: CHOP
Richard Wong, DO, explains challenges children with asthma face in school
Infectious Insights | Image Credit: Contemporary Pediatrics
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
© 2025 MJH Life Sciences

All rights reserved.